 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Each participant in this study will be
followed for one to three years after kidney transplant surgery. Participants will
be randomly assigned to receive
the study drug or placebo.
followed for one to three years after kidney transplant surgery. Participants will
be randomly assigned to receive
the study drug or placebo.
| Protocol | |
| The below documents are in PDF format. | |
| Protocol, v4.0 | Summary of Changes for v4.0 |
| Protocol Signature Page | Protocol 4 Clarification Memo #1 - 09JUL2019 |
| Protocol v4.0 Study Concept Sheet | Protocol 4 Clarification Memo #2 - 15APR2020 |
| Recipient Consent, v4.0 | Protocol 4 Clarification Memo #3 - 25MAY2021 |
| Donor Consent, v4,0 | Protocol 4 Clarification Memo #4 - 16DEC2021 |